Celator Pharmaceuticals, Inc. Appoints Joseph M. Lobacki To Board Of Directors

Published: Dec 19, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

EWING, N.J., Dec. 19, 2013 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, today announced the appointment of Joseph M. Lobacki to its Board of Directors.

Help employers find you! Check out all the jobs and post your resume.

Back to news